| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Mar, 2025 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -54,420 | -43,950 | -27,800 | -14,400 | 0 |
| Net Income Growth | -23.82% | -58.09% | -93.06% | unch | unch |
Longboard Pharmaceuticals Inc (LBPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
59.98 +0.02 (+0.03%) 11/29/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 59.98 unch (unch) -
for Fri, Nov 29th, 2024
Longboard Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel, transformative medicines for neurological diseases. Longboard Pharmaceuticals Inc. is based in SAN DIEGO.
Fiscal Year End Date: 12/31